Arbutus Biopharma Corp

NASDAQ:ABUS

3.17

-0.11 (-3.35%)

6:53:51 PM EDT: $3.16 -0.01 (-0.32%)

Market Cap (Intraday)	586.80M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.61 Million
Adjusted EPS	-$0.04

See more estimates

10-Day MA	$3.24
50-Day MA	$3.34
200-Day MA	$3.46

See more pivots

Arbutus Biopharma Corp Stock, NASDAQ:ABUS

701 Veterans Circle, Suite 100, Warminster, Pennsylvania 18974

United States of America

Phone: +1.267.469.0914

Number of Employees: 73

http://www.arbutusbio.com

Description

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.